Pharmafile Logo

Kraeber (UK) Ltd

The family owned business, Kraeber & Co GmbH, is an independent, technology based enterprise which was founded on the 1st January 1980 in Hamburg. Hanseatic tradition together with courageous entrepreneurship characterize our company. We are committed to open and global competition which we stand up with our service capabilities. Our emphasis is the development, production, marketing and sales of active pharmaceutical ingredients (APIs) of the highest purity. Kraeber has evolved into a niche marketer and supplier. By continously innovating productions, we became the quality market leader in Europe and in other parts of the world for many of our products.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

16 The Street, Saxon Street, Newmarket, Suffolk, CB8 9RU, United Kingdom
+44 (0)1638 731 297

 Latest Content from PMHub 

Genesis Research Insights & Evidence webinar 20 Oct: Reserve your place!

Join Priti Jhingran of Genesis Research and Tijana Ignjatovic of Market Access Transformation (MAT) for their webinar 'Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to...

WRG Launches Attendee Experience Design (AXD) Unit

WRG, the events and experiential division of The Creative Engagement Group, launches Attendee Experience Design (AXD) Unit. Combining Behavioural Science, Data Insights, and Digital and Live UX in One Unit

#Wellbeing Week: Let’s tackle pressure

White Papers and Resources | October 13, 2022 | Fox&Cat

Hear from Paul Hutchings, founder of foxandcat.online, with tips and advice to help your comms team thrive under pressure

The promised land of gene therapy: Commercialization of novel gene-editing technology in beta-thalassemia

With transformative treatments that leverage CRISPR technology, there are many challenges to overcome throughout the journey of development through to patient access. We interviewed a researcher at a top 20...

Infographic: Therapy Watch Psoriasis

White Papers and Resources | October 10, 2022 | Inizio

Our PsO infographic offers an introduction to the real-world patient insights collected by our Therapy Watch PsO study.

Porterhouse Insights celebrates its 5th anniversary

Porterhouse Medical Group is celebrating the 5th anniversary of Porterhouse Insights, its global research, insights and evidence consultancy.

Thought Leaders in Medical Affairs: Key Trends & Challenges Shaping the Future of the Medical Affairs Role

How can Medical Affairs divisions bring greater value to their organizations and practitioners every day?

Mobilizing Agitation Detection in Children with ADHD

Marius Rus, founder of StressLess–the startup behind Tully–discusses wearable technologies for children with ADHD, autism, and other mental health conditions. He also shares his tips and lessons learned from founding...

Onyx Health Goes for International Growth with New Managing Director

Press Releases | October 6, 2022 | Onyx Health

Onyx Health has announced the appointment of Trevor Pill as their new Managing Director. He will be taking over the day-to-day running of the agency from owner and founder Karen...

Lifting the fog to help Clinical Labs navigate IVDR 2022

In Vitro Diagnostic Regulation (IVDR 2022) was on the horizon: a new regulatory basis for laboratories to adhere to regarding their diagnostic equipment and tests.  BD wanted to let their customers...